A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 910,17 kr, with a 24-hour trading volume of 1,24B kr. The asset's market cap is 2,96T kr, after moving 6.14% in the last day.
Tokenized AstraZeneca PLC is trading at 1 092,9 kr, with a tokenized market cap of 618,77M kr and a 24-hour trading volume of 8,19M kr. The tokenized asset has moved 6.62% in the past 24 hours.